ClinicalTrials.gg
CompletedNCT05900128Updated Jul 12, 2024

Impact of Exercise on Ashtma in Adults

An interventional study of workshop and no workshop in Asthma and Physical Inactivity, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Completed at 1 site in Spain. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2024-07-12.

Sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

The aim of this study is to evaluate if physical activity could improve asthma control and management in adults. With this purpose we enroll asthmatic patients between 18-64 years old, and randomized them into 2 groups: in the first, patients will receive some workshops about asthma en physical exercise; in the second no educational intervention will be done. All patients will use a step counter in order to evaluate their activity during the study. Spirometric values and questionnaries about asthma control and quality of life will be recorded for all patients. Finally 2 groups will be comparated in order to search any difference in quality of life and asthma control.

Read the detailed description

52 asthmatic will be enrolled and randomized into 2 groups. All patients will send a weekly summary of their physical activity (mean number of steps and time of physical activity). All patients will be undergone to a medical visit at month 1 and 3 since study start. In each visit a spirometry, a FeNo, ACQ and AQLQ questionnaires will be done.

The patients of the intervention group will receive 3 workshops about asthma and physical exercise in order to provide information, medical support, and to resolve any question or difficulty about it. The workshops will be al week 1, 2 and 4 since study start.

02

Conditions studied

  • Asthma
  • Physical Inactivity

Keywords

  • asthma
  • sedentarism
  • spirometry
  • physical excercise
03

In context

Asthma

4,012 studies on the registry are indexed under Asthma; 514 are open to participants now.

This study's enrollment of 52 is below the median of 83 across 2,814 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz is the lead sponsor of 74 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • asthma well controlled
  • sedentarism (\<150 min physical activity/day and/or \<7000 daily steps)

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • cardiological, not well controlled deseases
  • other cronic pulmonary deseases
  • bad asthma control
  • not sign IC
  • unable to practice physical activity (for cognitive or physical conditions)
  • no devices able to count steps and physical activity
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Active comparator
    Intervention

    asthmatic patients who receive the educative intervention

    Behavioral: workshop

  • Placebo comparator
    no intervention

    asthmatic patients who don't receive the educative intervention

    Other: no workshop

Interventions

  • Behavioralworkshop

    Patients will receive workshops and they will encourage to practice physical activity

  • Otherno workshop

    patients won't receive educative workshops

06

What researchers measure

Primary outcomes

  1. Improvement of asthma control

    change of 0.5 points in Asthma Control Questionnaire (0-6; higher score means worse result)

    Time frame: 3 months

07

Study locations

1 site
  • Hospital Rey Juan Carlos
    Móstoles, Madrid 28933, Spain
08

References and documents

Individual participant data

Plan to share: No — Pending to decide if share the final report with other researchers

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05900128
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Responsible party
Sponsor
First posted
Jun 12, 2023
Start date
Jun 1, 2023
Primary completion
Feb 28, 2024
Completion
Feb 28, 2024
Last update
Jul 12, 2024

Study contacts

sarah micozzi, MD
principal investigator · Hospital Rey Juan Carlos-Instituto de Investigación FJD

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion